Expression and clinical significance of hypoxia-inducible factor-1 alpha after TACE on rabbit VX2 liver neoplasms
Creators
- 1. China Medical Univ., Shenyang (China). First Hospital, Dept. of Radiology
Description
Objective: To investigate expression and clinical significance of hypoxia-inducible factor-1 alpha (HIF-1α) after TACE on rabbit VX2 liver neoplasms, and the correlation with tumor angiogenesis. Methods: Twenty four rabbits implanted liver VX2 tumors were randomly divided into 3 groups. Control group was administrated with 2 ml saline. TAE group was embolized with 0.5 to 0.8 ml ultra-fluid lipiodol. TACE group was embolized with 0.5 to 0.8 ml ultra-fluid lipiodol mixed with 2 mg Pirarubicin. Two weeks after treatment, HIF-1α, VEGF expression was detected by immunohistochemistry, and microvessel density(MVD) of the section marked with CD34 antibody was calculated. Results: The expressions of HIF-1α, VEGF and MVD in TAE group and TACE group were stronger than those in control group (P<0.05) . HIF-1α was positively correlated with VEGF and MVD (r=0.537, P<0.01; r=0.423, P<0.05). Conclusion: Significant overexpression of HIF-1α was found after TAE and TACE. HIF-1α plays an important role in the prognosis of liver neoplasms by up-regulating the expression of VEGF and increasing MVD. (authors)
Additional details
Publishing Information
- Journal Title
- Journal of Interventional Radiology
- Journal Volume
- 16
- Journal Issue
- 5
- Journal Page Range
- p. 334-338
- ISSN
- 1008-794X
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 39001980
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ANOXIA; ARTERIES; BIOLOGICAL MODELS; BLOOD VESSELS; CHEMOTHERAPY; CLINICAL TRIALS; DENSITY; DOXORUBICIN; EMBOLI; ENDOTHELIUM; GENE REGULATION; GROWTH FACTORS; LIPIODOL; LIVER; NEOPLASMS; RABBITS
- Descriptors DEC
- ANIMAL TISSUES; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIBIOTICS; ANTINEOPLASTIC DRUGS; BLOOD VESSELS; BODY; CARDIOVASCULAR SYSTEM; CONTRAST MEDIA; DIGESTIVE SYSTEM; DISEASES; DRUGS; GLANDS; MAMMALS; MEDICINE; MITOGENS; OILS; ORGANIC COMPOUNDS; ORGANIC HALOGEN COMPOUNDS; ORGANIC IODINE COMPOUNDS; ORGANS; OTHER ORGANIC COMPOUNDS; PHYSICAL PROPERTIES; PROTEINS; TESTING; THERAPY; VERTEBRATES
Optional Information
- Notes
- 6 figs., 2 tabs., 9 refs.